Clinical Trials · NCT00754442

Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism

Name: Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ATeriparatide

Phase: N/A
Recruitment status: Completed
Sponsor: University of Maryland, Baltimore
Enrollment: 20
Start date: Feb 2007
Locations: 1 site, United States
Primary endpoint: The Level of Activated Vitamin D (1,25-dihydroxyvitamin D) After Parathyroid Hormone Infusion at Baseline, 4 and 8 Hours

View Teriparatide compound reference